Literature DB >> 25572511

Low-gradient, low-flow severe aortic stenosis with preserved left ventricular ejection fraction: characteristics, outcome, and implications for surgery.

Christophe Tribouilloy1, Dan Rusinaru2, Sylvestre Maréchaux3, Anne-Laure Castel4, Nicolas Debry3, Julien Maizel5, Romuald Mentaverri5, Said Kamel5, Michel Slama5, Franck Lévy6.   

Abstract

BACKGROUND: Severe low-gradient, low-flow (LG/LF) aortic stenosis with preserved left ventricular ejection fraction (EF) has been described as a more advanced form of aortic stenosis. However, the natural history and need for surgery in patients with LG/LF aortic stenosis remain subjects of intense debate.
OBJECTIVES: We sought to investigate the outcome of LG/LF aortic stenosis in comparison with moderate aortic stenosis and with high-gradient (HG) aortic stenosis in a real-world study, in the context of routine practice.
METHODS: This analysis included 809 patients (ages 75 ± 12 years) diagnosed with aortic stenosis and preserved EF (≥50%). Patients were divided into 4 groups: mild-to-moderate aortic stenosis; HG aortic stenosis; LG/LF aortic stenosis; and low-gradient, normal-flow (LG/NF) aortic stenosis.
RESULTS: Compared with mild-to-moderate aortic stenosis patients, LG/LF aortic stenosis patients had smaller valve areas and stroke volumes, higher mean gradients, and comparable degrees of ventricular hypertrophy. Under medical management (22.8 months; range 7 to 53 months), compared with mild-to-moderate aortic stenosis patients, HG aortic stenosis patients were at higher risk of death (adjusted hazard ratio [HR]: 1.47; 95% confidence interval [CI]: 1.03 to 2.07), whereas LG/LF aortic stenosis patients did not have an excess mortality risk (adjusted HR: 0.88; 95% CI: 0.53 to 1.48). During the entire (39.0 months; range 11 to 69 months) follow-up (with medical and surgical management), the mortality risk associated with LG/LF aortic stenosis was close to that of mild-to-moderate aortic stenosis (adjusted HR: 0.96; 95% CI: 0.58 to 1.53), whereas the excess risk of death associated with HG aortic stenosis was confirmed (adjusted HR: 1.74; 95% CI: 1.27 to 2.39). The benefit associated with aortic valve replacement was confined to the HG aortic stenosis group (adjusted HR: 0.29; 95% CI: 0.18 to 0.46) and was not observed for LG/LF aortic stenosis (adjusted HR: 0.75; 95% CI: 0.14 to 4.05).
CONCLUSIONS: In this study, the outcome of severe LG/LF aortic stenosis with preserved EF was similar to that of mild-to-moderate aortic stenosis and was not favorably influenced by aortic surgery. Further research is needed to better understand the natural history and the progression of LG/LF aortic stenosis.
Copyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  aortic valve; cardiac surgical procedures; follow-up studies; mortality

Mesh:

Year:  2015        PMID: 25572511     DOI: 10.1016/j.jacc.2014.09.080

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  25 in total

Review 1.  Pathophysiology of Aortic Valve Stenosis: Is It Both Fibrocalcific and Sex Specific?

Authors:  Yoginee Sritharen; Maurice Enriquez-Sarano; Hartzell V Schaff; Grace Casaclang-Verzosa; Jordan D Miller
Journal:  Physiology (Bethesda)       Date:  2017-05

Review 2.  Low-flow/low-gradient aortic stenosis-Still a diagnostic and therapeutic challenge.

Authors:  Anja Vogelgesang; Gerd Hasenfuss; Claudius Jacobshagen
Journal:  Clin Cardiol       Date:  2017-05-23       Impact factor: 2.882

3.  Patterns of left ventricular remodeling in aortic stenosis: therapeutic implications.

Authors:  Sammy Elmariah
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-07

4.  Clinical and echocardiographic features of paradoxical low-flow and normal-flow severe aortic stenosis patients with concomitant mitral regurgitation.

Authors:  Jinghao Nicholas Ngiam; Nicholas Chew; Rebecca Teng; Jonathan D Kochav; Stephanie M Kochav; Benjamin Yong-Qiang Tan; Hui Wen Sim; Ching-Hui Sia; William K F Kong; Edgar Lik Wui Tay; Tiong-Cheng Yeo; Kian-Keong Poh
Journal:  Int J Cardiovasc Imaging       Date:  2019-11-27       Impact factor: 2.357

Review 5.  Calcific Aortic Valve Disease: Part 1--Molecular Pathogenetic Aspects, Hemodynamics, and Adaptive Feedbacks.

Authors:  Ares Pasipoularides
Journal:  J Cardiovasc Transl Res       Date:  2016-02-18       Impact factor: 4.132

6.  Clinical outcome and functional characteristics of patients with asymptomatic low-flow low-gradient severe aortic stenosis with preserved ejection fraction are closer to high-gradient severe than to moderate aortic stenosis.

Authors:  Mohammad Kavianipour; Amir Farkhooy; Frank A Flachskampf
Journal:  Int J Cardiovasc Imaging       Date:  2017-11-09       Impact factor: 2.357

Review 7.  Diagnosis and management of patients with asymptomatic severe aortic stenosis.

Authors:  Minako Katayama; Hari P Chaliki
Journal:  World J Cardiol       Date:  2016-02-26

Review 8.  Workup and Management of Patients With Paradoxical Low-Flow, Low-Gradient Aortic Stenosis.

Authors:  Mohamed-Salah Annabi; Marine Clisson; Marie-Annick Clavel; Philippe Pibarot
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-05-02

Review 9.  Low-gradient aortic stenosis.

Authors:  Marie-Annick Clavel; Julien Magne; Philippe Pibarot
Journal:  Eur Heart J       Date:  2016-03-31       Impact factor: 29.983

10.  Insights into the mechanism of paradoxical low-flow, low-pressure gradient severe aortic stenosis: association with reduced O2 consumption by the whole body.

Authors:  Takeshi Onoue; Mai Iwataki; Masaru Araki; Hideaki Itoh; Akihiro Isotani; Hiromi Umeda; Shota Fukuda; Yasufumi Nagata; Yuki Tsuda; Yoshihisa Fujino; Michiya Hanyu; Kenji Ando; Shinichi Shirai; Masaaki Takeuchi; Satoru Saeki; Robert A Levine; Yutaka Otsuji
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-01-25       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.